BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16020906)

  • 1. Hepatic amyloidosis manifesting severe intrahepatic cholestasis.
    Kitamura Y; Yokomori H
    Intern Med; 2005 Jun; 44(6):675-6. PubMed ID: 16020906
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic amyloidosis presenting with severe intrahepatic cholestasis.
    Goenka MK; Bhasin DK; Vasisth RK; Dhawan S
    J Clin Gastroenterol; 1996 Sep; 23(2):134-6. PubMed ID: 8877643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging with liver-specific contrast agent in primary amyloidosis and intrahepatic cholestasis.
    Møller JM; Santoni-Rugiu E; Chabanova E; Løgager V; Hansen AB; Thomsen HS
    Acta Radiol; 2007 Mar; 48(2):145-9. PubMed ID: 17354133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AL-type amyloidosis presenting with rapidly deteriorating liver involvement.
    Linardaki G; Drivas G; Archimandritis A
    J Clin Gastroenterol; 1997 Jun; 24(4):297-8. PubMed ID: 9252870
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of prominent hepatic cholestasis developing to hepatic failure in lambda-AL amyloidosis.
    Dohmen K; Nagano M; Iwakiri R; Yamano Y; Kikuchi Y; Mizoguchi M; Iwata Y; Mori Y; Ishibashi H
    Gastroenterol Jpn; 1991 Jun; 26(3):376-81. PubMed ID: 1889693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A rare case of cholestasis and macrohematuria in a 52-year-old patient].
    Arkenau HT; Widjaja A
    Med Klin (Munich); 2002 Aug; 97(8):480-3. PubMed ID: 12229247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe recurrent intrahepatic cholestasis in systemic AL amyloidosis without evident liver involvement. Unexplained hepatic toxicity or a case of misdiagnosed liver amyloidosis?
    Paudice N; Farsetti S; Caroti L; Ciuti G; Tempestini A; Perfetto F; Bergesio F
    Amyloid; 2011 Jun; 18 Suppl 1():142-4. PubMed ID: 21838465
    [No Abstract]   [Full Text] [Related]  

  • 8. [Severe recurrent intrahepatic cholestasis in systemic AL amyloidosis without obvious liver involvement: unexplained hepatic toxicity or a case of misdiagnosed liver amyloidosis?].
    Paudice N; Farsetti S; Caroti L; Bandini S; Ciuti G; Tempestini A; Perfetto F; Galli S; Giabbani L; Caldini AL; Bergesio F
    G Ital Nefrol; 2012; 29(1):92-7. PubMed ID: 22388910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case report of systematic amyloid with hepatic function abnormal].
    Cao LL; Zhao B; Lai W; Luo ZG; Chen XP
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):71. PubMed ID: 20128978
    [No Abstract]   [Full Text] [Related]  

  • 10. A man with new onset of ascites and edema.
    Lau M
    Medscape J Med; 2008 Apr; 10(4):83. PubMed ID: 18504476
    [No Abstract]   [Full Text] [Related]  

  • 11. [Primary amyloidosis of the gastrointestinal tract and liver--two case reports].
    Halm U; Berr F; Eggers E; Wohlgemuth B; Mössner J
    Z Gastroenterol; 1997 Feb; 35(2):131-7. PubMed ID: 9163226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huge hepatomegaly, jaundice and portal hypertension due to amyloidosis of the liver.
    Melkebeke P; Vandepitte J; Hannon R; Fevery J
    Digestion; 1980; 20(5):351-7. PubMed ID: 7390060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloma and severe cholestasis.
    Licht A; Maurer R; Oelz O
    Schweiz Med Wochenschr; 1999 Aug; 129(34):1201-4. PubMed ID: 10486860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary amyloidosis as a rare cause of acute liver insufficiency].
    Diel R; Krüger C
    Dtsch Med Wochenschr; 1988 Sep; 113(37):1433-6. PubMed ID: 3416761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary systemic amyloidosis with giant hepatomegaly and a swiftly progressive course.
    Mainenti PP; Petrelli G; Lamanda R; Amalfi G; Castiglione F
    J Clin Gastroenterol; 1997 Apr; 24(3):173-5. PubMed ID: 9179738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal hypertension and intrahepatic cholestasis in primary amyloidosis.
    Çağlar E; Özbay G; Kalyon H; Sonsuz A
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():258-9. PubMed ID: 25910329
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe intrahepatic cholestasis, erythrocytosis and hypoglycemia: unusual presenting features of systemic AL amyloidosis.
    Ferreira S; Baldaia C; Fatela N; Ramalho F; Costa MA; Brito D; Esteves G; Monteiro E
    Scand J Gastroenterol; 2008 Mar; 43(3):375-9. PubMed ID: 18938770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholestasis and renal failure in a patient with secondary amyloidosis.
    Unsal C; Paydaş S; Gönlüşen G
    Ren Fail; 2002 Nov; 24(6):863-6. PubMed ID: 12472208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary amyloidosis presenting as intrahepatic cholestasis.
    Bandyopadhyay SK; Bandyopadhyay R; Dutta A
    Indian J Pathol Microbiol; 2006 Oct; 49(4):557-9. PubMed ID: 17183853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AApoAIL75P amyloidosis causes cirrhosis-like appearance of the liver in the absence of laboratory or clinical signs of hepatic dysfunction.
    Avsar Y; Spieker T; Kabar I; Roecken C; Wolters H; Schmidt H
    Amyloid; 2014 Jun; 21(2):128-30. PubMed ID: 24669943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.